Cargando…

The E/e’ ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies

Type 2 diabetes is associated with an increased risk of heart failure. Left ventricular diastolic dysfunction and type 2 diabetes are frequently associated. Using echocardiography, we know that tissue Doppler imaging E/e’ ratio is a reliable predictor of left ventricular filling pressure. We perform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zoppini, Giacomo, Bergamini, Corinna, Mantovani, Alessandro, Dauriz, Marco, Targher, Giovanni, Rossi, Andrea, Bonora, Enzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307698/ https://www.ncbi.nlm.nih.gov/pubmed/30589892 http://dx.doi.org/10.1371/journal.pone.0209794

Ejemplares similares

Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2020)

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2015)

The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
por: Mantovani, Alessandro, et al.
Publicado: (2017)

Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2012)

Glycated Haemoglobin Is Inversely Related to Serum Vitamin D Levels in Type 2 Diabetic Patients
por: Zoppini, Giacomo, et al.
Publicado: (2013)

Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients
por: Zoppini, Giacomo, et al.
Publicado: (2009)

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance
por: Cacciatori, Vittorio, et al.
Publicado: (2017)

High-Normal HbA(1c) Is a Strong Predictor of Type 2 Diabetes in the General Population
por: Bonora, Enzo, et al.
Publicado: (2011)

Aortic and Mitral Annular Calcifications Are Predictive of All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Rossi, Andrea, et al.
Publicado: (2012)

Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
por: Zoppini, Giacomo, et al.
Publicado: (2012)

Lower levels of 25-hydroxyvitamin D(3) are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2015)

Diabetes as a cause of death across different COVID-19 epidemic waves
por: Fedeli, Ugo, et al.
Publicado: (2022)

Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9
por: Bonora, Enzo, et al.
Publicado: (2020)

Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study
por: Mantovani, Alessandro, et al.
Publicado: (2016)

A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy
por: Marchetti, Luca, et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2013)

SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people
por: Bonora, Enzo, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
por: Bonapace, Stefano, et al.
Publicado: (2012)

Metabolic Effects of Aerobic Training and Resistance Training in Type 2 Diabetic Subjects: A randomized controlled trial (the RAED2 study)
por: Bacchi, Elisabetta, et al.
Publicado: (2012)

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
por: Valbusa, Filippo, et al.
Publicado: (2017)

Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population
por: De Santi, F., et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure
por: Valbusa, Filippo, et al.
Publicado: (2016)

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10
por: Bonora, Enzo, et al.
Publicado: (2022)

Time series of diabetes attributable mortality from 2008 to 2017
por: Fedeli, U., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
por: Bonapace, Stefano, et al.
Publicado: (2014)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Honey dressing on a leg ulcer with tendon exposure in a patient with type 2 diabetes
por: Teobaldi, Ilaria, et al.
Publicado: (2018)

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
por: Inciardi, Riccardo M., et al.
Publicado: (2023)

Prolonged Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Type 2 Diabetes Mellitus
por: Tokatli, Alptug, et al.
Publicado: (2016)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
por: Mantovani, Alessandro, et al.
Publicado: (2016)

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
por: Lonardo, Amedeo, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

La pandemia diabete in Italia
por: Bonora, Enzo
Publicado: (2022)

CACNA1E Variants Affect Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 3
por: Trombetta, Maddalena, et al.
Publicado: (2012)

Differences in the Acute Effects of Aerobic and Resistance Exercise in Subjects with Type 2 Diabetes: Results from the RAED2 Randomized Trial
por: Bacchi, Elisabetta, et al.
Publicado: (2012)

Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e0t6pie9msgg94ghm03r7crlni